Publication details
Význam 18F-FDG-PET vyšetření v léčbě adenokarcinomu jícnu a gastroezofageální junkce – přehled
| Title in English | The value of 18F-FDG-PET testing in the management of esophageal and gastroesophageal junction adenocarcinoma - review |
|---|---|
| Authors | |
| Year of publication | 2021 |
| Type | Article in Periodical |
| Magazine / Source | Klinická onkologie |
| MU Faculty or unit | |
| Citation | |
| web | Klinická onkologie |
| Doi | http://dx.doi.org/10.48095/ccko2021113 |
| Keywords | gastroesophageal junction adenocarcinoma; esophageal adenocarcinoma; positron emission tomography; computed tomography (PET / CT); personalized therapy |
| Description | Preoperative chemoradiotherapy (CRT) and perioperative chemotherapy (CHMT) are a standard of care for distal esophageal and gastroesophageal junction adenocarcinomas. PET / CT using 18F-fluorodeoxyglucose (18F-FDG-PET / CT) is one of the basic staging examinations with a certain prognostic significance and has recently been studied for the possibility of showing prognostic or predictive results suitable for the individualization of treatment strategy. Purpose: The aim of this review is to map the role of 18F-FDG-PET / CT in predicting the response to CHMT and CRT, which could be a starting point for personalized treatment. |